The historical rank and industry rank for MicroPort CardioFlow Medtech's Pretax Margin % or its related term are showing as below:
FRA:72X0'
s Pretax Margin % Range Over the Past 10 Years
Min: -672.15 Med: -137.88 Max: -12.8
Current: -31.46
FRA:72X0's Pretax Margin % is ranked worse than 71.6% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs FRA:72X0: -31.46
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
MicroPort CardioFlow Medtech Pretax Margin % Related Terms
MicroPort CardioFlow Medtech Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:72X0 vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort CardioFlow Medtech Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where MicroPort CardioFlow Medtech's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroPort CardioFlow Medtech (FRA:72X0) has a Pretax Margin % of -72.37% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on MicroPort CardioFlow Medtech and its competitors. According to the industry distribution chart, MicroPort CardioFlow Medtech ranks #585 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 71.6%.
Is MicroPort CardioFlow Medtech's Pretax Margin % too high?
MicroPort CardioFlow Medtech's current Pretax Margin % is -72.37%. Based on the distribution chart, MicroPort CardioFlow Medtech ranks #585 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, MicroPort CardioFlow Medtech has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort CardioFlow Medtech's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort CardioFlow Medtech ranks #585 out of 817 companies for Pretax Margin %. This places MicroPort CardioFlow Medtech in the lower half of its industry. The industry median Pretax Margin % is 2.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.43, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on MicroPort CardioFlow Medtech and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort CardioFlow Medtech's current Pretax Margin % is -72.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort CardioFlow Medtech stock overvalued right now?
Based on GuruFocus' analysis, MicroPort CardioFlow Medtech (FRA:72X0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.61, compared to a current price of €0.12 — trading 80.3% below its estimated fair value. The current Pretax Margin % is -72.37%. MicroPort CardioFlow Medtech's overall GF Score™ is 35/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For MicroPort CardioFlow Medtech (FRA:72X0), the current Pretax Margin % is -72.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort CardioFlow Medtech (FRA:72X0) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort CardioFlow Medtech stock appears to be undervalued.
The current stock price of €0.12 is trading 80.3% below its estimated GF Value™ of €0.61.
GuruFocus considers MicroPort CardioFlow Medtech to be Possible Value Trap.
Key valuation signals for FRA:72X0:
Pretax Margin %: -72.37%
GF Value™: €0.61 vs. price of €0.12 (80.3% below fair value)
No single metric tells the full story. See the FRA:72X0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, Angelguide and AnchorMan. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
35GF Score
Get the complete analysis for FRA:72X0
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:72X0 has been successfully added to your 
